Merck giving up on two potential COVID-19 vaccines after poor test results

Merck is halting work on two potential COVID-19 vaccines following poor results in early-stage studies.The drugmaker said it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators.